Search
Vistagen Therapeutics Inc
VTGNAdd to Watchlist
0.241USD
0.0000.00%
Close 07-31 16:00（ET）Quotes delayed by 15 min
9.55MMarket Cap
LossP/E TTM
Vistagen Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Vistagen Therapeutics Inc is 8.53, ranking 87 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.13, which is -94.82% below the recent high of -0.01 and -3297.73% above the recent low of -4.33.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.